Evaluate PK Profile
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults (NCT04840849) | AstraZeneca | 2021-06-22 |
Track Evaluate PK Profile automatically
Every clearance here is in the API, with alerts when new ones post.